this post was submitted on 09 Dec 2024
8 points (90.0% liked)

Politics

361 readers
42 users here now

For civil discussion of US politics. Be excellent to each other.

Rule 1: Posts have the following requirements:
▪️ Post articles about the US only

▪️ Title must match the article headline

▪️ Recent (Past 30 Days)

▪️ No Screenshots/links to other social media sites or link shorteners

Rule 2: Do not copy the entire article into your post. One or two small paragraphs are okay.

Rule 3: Articles based on opinion (unless clearly marked and from a serious publication-No Fox News or equal), misinformation or propaganda will be removed.

Rule 4: Posts or comments that are homophobic, transphobic, racist, sexist, ableist, will be removed.

Rule 5: Keep it civil. It’s OK to say the subject of an article is behaving like a jerk. It’s not acceptable to say another user is a jerk. Cussing is fine.

Rule 6: Memes, spam, other low effort posting, reposts, advocating violence, off-topic, trolling, offensive, regarding the moderators or meta in content may be removed at any time.

USAfacts.org

The Alt-Right Playbook

Media owners, CEOs and/or board members

founded 2 years ago
MODERATORS
 

Earlier this fall, the Centers for Disease Control and Prevention reported data showing that adult obesity rates—long trending upwards—had fallen modestly over the past few years, from 41.9 to 40.3 percent. The decline sparked discussion on social media and in major news outlets about whether the US has passed so-called “peak obesity”—and whether the growing use of certain weight-loss drugs might account for the shift.

Still, it is premature to declare that GLP-1s have caused overall declining obesity rates in the US. There are a number of ways to interpret the CDC data, and not all of them suggest that obesity rates have actually fallen. Further, recent evidence indicates that GLP-1s might not be as effective for weight loss as initially thought. And there are reasons to question the comparison to cigarette sales. Taken together, all of this suggests that we may need to wait to understand how this new class of drugs affects weight loss at the population level.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here